| 产品详情 |
| Edit |   |
|---|
| Product Name | BCL11B Recombinant Protein Antigen |
|---|
| Description | Purity >80% by SDS-PAGE and Coomassie blue staining. MW (theoretical): 23 kDa. The BCL11B Recombinant Protein Antigen from Novus Biologicals is derived from E. coli. The BCL11B Recombinant Protein Antigen has been validated for the following applications: Antibody Competition. |
|---|
| Size | 0.1 ml |
|---|
| Concentration | n/a |
|---|
| Applications | Antibody Competition |
|---|
| Other Names | B-cell CLL/lymphoma 11B, B-cell CLL/lymphoma 11B (zinc finger protein), B-cell CLL/lymphoma 11B/T-cell receptor delta constant region fusion protein, B-cell lymphoma/leukaemia 11B, B-cell lymphoma/leukemia 11B, BCL-11B, BCL11B/TRDC fusion, COUP-TF-interacting protein 2, CTIP-2, CTIP2ZNF856B, hRit1, hRIT1-alpha, Radiation-induced tumor suppressor gene 1 protein, RIT1, zinc finger protein hRit1 alpha |
|---|
| Gene, Accession, CAS # | BCL11B, Gene ID: 64919 |
|---|
| Catalog # | NBP2-33549PEP |
|---|
| Price | |
|---|
| Order / More Info | BCL11B Recombinant Protein Antigen from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|